{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:19:42Z","timestamp":1771467582056,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Syst"],"DOI":"10.1007\/s10916-023-01929-0","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T08:04:11Z","timestamp":1679990651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Investigation of Atypical Cell Parameter in the Surveillance of Patients with NMIBC; Initial Outcomes of a Single Center Prospective Study"],"prefix":"10.1007","volume":"47","author":[{"given":"Murat Can","family":"Karaburun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Fatih","family":"\u00d6zkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berrin \u0130mge","family":"Erg\u00fcder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evren","family":"S\u00fcer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"1929_CR1","doi-asserted-by":"crossref","unstructured":"Babjuk M, Burger M, Capoun O, et al: European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). Eur Urol, 2021","DOI":"10.1016\/j.eururo.2021.08.010"},{"key":"1929_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424, 2018","journal-title":"CA Cancer J Clin"},{"key":"1929_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0140-6736(09)60491-8","volume":"374","author":"DS Kaufman","year":"2009","unstructured":"Kaufman DS, Shipley WU, Feldman AS: Bladder cancer. Lancet 374:239\u201349, 2009","journal-title":"Lancet"},{"key":"1929_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/bju.14557","volume":"123","author":"R Suarez-Ibarrola","year":"2019","unstructured":"Suarez-Ibarrola R, Soria F, Abufaraj M, et al: Surgical checklist impact on recurrence-free survival of patients with non-muscle-invasive bladder cancer undergoing transurethral resection of bladder tumour. BJU Int 123:646\u2013650, 2019","journal-title":"BJU Int"},{"key":"1929_CR5","doi-asserted-by":"publisher","first-page":"66.e25-31","DOI":"10.1016\/j.urolonc.2014.06.008","volume":"33","author":"FA Yafi","year":"2015","unstructured":"Yafi FA, Brimo F, Steinberg J, et al: Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urol Oncol 33:66.e25-31, 2015","journal-title":"Urol Oncol"},{"issue":"Suppl 2","key":"1929_CR6","first-page":"S53-9","volume":"22","author":"B T\u00eatu","year":"2009","unstructured":"T\u00eatu B: Diagnosis of urothelial carcinoma from urine. Mod Pathol 22 Suppl 2:S53-9, 2009","journal-title":"Mod Pathol"},{"key":"1929_CR7","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00345-018-2380-x","volume":"36","author":"F Soria","year":"2018","unstructured":"Soria F, Droller MJ, Lotan Y, et al: An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer. World J Urol 36:1981\u20131995, 2018","journal-title":"World J Urol"},{"key":"1929_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, et al: European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). Eur Urol 81:75\u201394, 2022","journal-title":"Eur Urol"},{"key":"1929_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13000-020-00993-1","volume":"15","author":"C Ren","year":"2020","unstructured":"Ren C, Wang X, Yang C, et al: Investigation of Atyp.C using UF-5000 flow cytometer in patients with a suspected diagnosis of urothelial carcinoma: a single-center study. Diagn Pathol 15:77, 2020","journal-title":"Diagn Pathol"},{"key":"1929_CR10","unstructured":"D.L. R: The Paris System for Reporting Urinary Cytology., Springer, 2016"},{"key":"1929_CR11","doi-asserted-by":"publisher","first-page":"113763","DOI":"10.1016\/j.ab.2020.113763","volume":"600","author":"O Aydin","year":"2020","unstructured":"Aydin O: Atypical cells parameter in an automated urine analyzer: Does it have a future? Anal Biochem 600:113763, 2020","journal-title":"Anal Biochem"},{"key":"1929_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13000-021-01068-5","volume":"16","author":"O Aydin","year":"2021","unstructured":"Aydin O: Atypical cells parameter in Sysmex UN automated urine analyzer: feedback from the field. Diagn Pathol 16:9, 2021","journal-title":"Diagn Pathol"},{"key":"1929_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000446270","volume":"60","author":"GA Barkan","year":"2016","unstructured":"Barkan GA, Wojcik EM, Nayar R, et al: The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology. Acta Cytol 60:185\u201397, 2016","journal-title":"Acta Cytol"},{"key":"1929_CR14","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/j.1464-410X.2006.06036.x","volume":"97","author":"PI Karakiewicz","year":"2006","unstructured":"Karakiewicz PI, Benayoun S, Zippe C, et al: Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder. BJU Int 97:997\u20131001, 2006","journal-title":"BJU Int"},{"key":"1929_CR15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0302-2838(02)00006-4","volume":"41","author":"MP Raitanen","year":"2002","unstructured":"Raitanen MP, Aine R, Rintala E, et al: Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis. Eur Urol 41:284\u20139, 2002","journal-title":"Eur Urol"},{"key":"1929_CR16","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/BF03262330","volume":"21","author":"MF Botteman","year":"2003","unstructured":"Botteman MF, Pashos CL, Redaelli A, et al: The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 21:1315\u201330, 2003","journal-title":"Pharmacoeconomics"},{"key":"1929_CR17","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s00345-018-2550-x","volume":"37","author":"M Mossanen","year":"2019","unstructured":"Mossanen M, Wang Y, Szymaniak J, et al: Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories. World J Urol 37:2059\u20132065, 2019","journal-title":"World J Urol"},{"key":"1929_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.eururo.2012.09.057","volume":"63","author":"AM Kamat","year":"2013","unstructured":"Kamat AM, Hegarty PK, Gee JR, et al: ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers. Eur Urol 63:4\u201315, 2013","journal-title":"Eur Urol"},{"key":"1929_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.urology.2007.08.014","volume":"71","author":"YM Hong","year":"2008","unstructured":"Hong YM, Loughlin KR: Economic impact of tumor markers in bladder cancer surveillance. Urology 71:131\u20135, 2008","journal-title":"Urology"},{"key":"1929_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/JU.0000000000001084","volume":"204","author":"M Roupret","year":"2020","unstructured":"Roupret M, Gontero P, McCracken SRC, et al: Diagnostic Accuracy of MCM5 for the Detection of Recurrence in Nonmuscle Invasive Bladder Cancer Followup: A Blinded, Prospective Cohort, Multicenter European Study. J Urol 204:685\u2013690, 2020","journal-title":"J Urol"},{"key":"1929_CR21","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.eururo.2018.11.055","volume":"75","author":"F Valenberg","year":"2019","unstructured":"Valenberg F, Hiar AM, Wallace E, et al: Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer. Eur Urol 75:853\u2013860, 2019","journal-title":"Eur Urol"},{"key":"1929_CR22","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","volume":"196","author":"SS Chang","year":"2016","unstructured":"Chang SS, Boorjian SA, Chou R, et al: Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA\/SUO Guideline. J Urol 196:1021\u20139, 2016","journal-title":"J Urol"},{"key":"1929_CR23","doi-asserted-by":"crossref","unstructured":"Yossepowitch O, Herr HW, Donat SM: Use of urinary biomarkers for bladder cancer surveillance: patient perspectives. J Urol 177:1277\u201382; discussion 1282, 2007","DOI":"10.1016\/j.juro.2006.11.066"}],"container-title":["Journal of Medical Systems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10916-023-01929-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10916-023-01929-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10916-023-01929-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T06:10:54Z","timestamp":1703830254000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10916-023-01929-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1929"],"URL":"https:\/\/doi.org\/10.1007\/s10916-023-01929-0","relation":{},"ISSN":["1573-689X"],"issn-type":[{"value":"1573-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]},"assertion":[{"value":"7 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"All data is gathered and analysed after geting ethical approve from Ankara University Ethics Comitee and consents from the patients for participation. Instutuional review board number is \u201ci01-45-22\u201d.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"No animal data has been used in our study. All the data gethered from human participants are applicable in accordance with the 1964 Helsinki Declaration.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Ethics"}},{"value":"All the authors of this paper, Murat Can Karaburun, Mehmet Fatih \u00d6zkaya, Berrin \u0130mge Erg\u00fcder, Evren S\u00fcer have consents fort his paper to be published in Journal of Medical Systems.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"41"}}